UnknownPhase 2NCT00781261

Osteonecrosis of the Hip and Bisphosphonate Treatment

Studying Osteonecrosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Sydney
Principal Investigator
Philip Sambrook, Prof
University of Sydney
Intervention
Zoledronic Acid(drug)
Enrollment
120 target
Eligibility
18-90 years · All sexes
Timeline
20092013

Study locations (5)

Collaborators

Novartis

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00781261 on ClinicalTrials.gov

Other trials for Osteonecrosis

Additional recruiting or active studies for the same condition.

See all trials for Osteonecrosis

← Back to all trials